TS-172 Phase 3 Hyperphosphatemia Peritoneal Dialysis Trial
Summary
A Phase 3 clinical trial evaluating TS-172 for the treatment of hyperphosphatemia in patients undergoing peritoneal dialysis has been registered on ClinicalTrials.gov. The trial is listed as NCT07548853 and is categorized under the Phase 3 filter on the registry. No recruitment status, enrollment figures, or trial endpoints are detailed in the available registration record.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.
What changed
A Phase 3 clinical trial investigating TS-172 as a treatment for hyperphosphatemia among peritoneal dialysis patients has been registered with ClinicalTrials.gov under identifier NCT07548853. The trial appears in the registry filtered by Phase 3 start date, indicating it has been initiated or is recruiting. No additional details regarding study design, primary endpoints, sample size, or anticipated completion date are provided in the available record.
Sponsors and investigators seeking to track competitive Phase 3 activity in the hyperphosphatemia treatment space should monitor this registry entry for updates on enrollment status and trial outcomes. Patients and advocacy groups focused on renal care may find this trial of interest as it represents a potential new therapeutic option for a population with limited alternatives.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.